PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.00%
Positive revenue growth while ECL.AX is negative. John Neff might see a notable competitive edge here.
8.77%
Positive gross profit growth while ECL.AX is negative. John Neff would see a clear operational edge over the competitor.
75.69%
Positive EBIT growth while ECL.AX is negative. John Neff might see a substantial edge in operational management.
75.69%
Positive operating income growth while ECL.AX is negative. John Neff might view this as a competitive edge in operations.
77.97%
Positive net income growth while ECL.AX is negative. John Neff might see a big relative performance advantage.
100.00%
Positive EPS growth while ECL.AX is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
66.67%
Positive diluted EPS growth while ECL.AX is negative. John Neff might view this as a strong relative advantage in controlling dilution.
31.77%
Slight or no buybacks while ECL.AX is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
9.28%
Slight or no buyback while ECL.AX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
311.99%
OCF growth under 50% of ECL.AX's 2901.55%. Michael Burry might suspect questionable revenue recognition or rising costs.
225.39%
FCF growth under 50% of ECL.AX's 2954.84%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-87.28%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-74.73%
Negative 5Y CAGR while ECL.AX stands at 0.16%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-64.55%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
-74.79%
Negative 5Y OCF/share CAGR while ECL.AX is at 32.09%. Joel Greenblatt would question the firm’s operational model or cost structure.
321.80%
3Y OCF/share CAGR above 1.5x ECL.AX's 45.08%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
-100.57%
Negative 10Y net income/share CAGR while ECL.AX is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
61.50%
Below 50% of ECL.AX's 248.34%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
93.84%
Positive short-term CAGR while ECL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.55%
Our AR growth while ECL.AX is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-7.33%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
7.41%
Asset growth above 1.5x ECL.AX's 0.94%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-129.89%
We have a declining book value while ECL.AX shows 0.37%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.94%
We expand SG&A while ECL.AX cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.